Table 2.
Health information related to contact screening and IPT initiation of PTB+ patients in Bahir Dar special zone, northwest Ethiopia, March 2016 (N = 255).
| Variable | Category | Frequency | Percent |
|---|---|---|---|
| Informed about contact screening | Yes | 230 | 90.2 |
| No | 25 | 9.8 | |
| Practice contact screening (N = 230) | Yes | 149 | 64.8 |
| No | 81 | 35.2 | |
| Outcome of contact screening | Positive | 11 | 7.4 |
| Negative | 138 | 92.6 | |
| Informed about the presence of IPT | Yes | 82 | 32.2 |
| No | 173 | 67.8 | |
| Started to use IPT (N = 138) | Yes | 44 | 31.9 |
| No | 94 | 68.1 | |
| HIV status (N = 230) | Positive | 34 | 14.8 |
| Negative | 196 | 85.2 | |
| Place of service provision (N = 230) | Health center | 190 | 82.6 |
| Hospital | 40 | 17.4 |
IPT: isoniazid preventive therapy; PTB+: smear-positive pulmonary tuberculosis; HIV: human immuno virus.